Oragenics Inc (NYSE MKT LLC:OGEN)

1.04
Data as of 9:35am ET
 -0.001 / -0.10%
Today’s Change
0.89
Today|||52-Week Range
4.65
-63.02%
Year-to-Date
SECTOR
Health Technology
INDUSTRY
Biotechnology
MARKET CAP
$37.6M

Company Description

Oragenics, Inc. is a biopharmaceutical company, which is focused on oral probiotics products and novel antibiotics for humans and companion pets. It also develops, markets and sells proprietary probiotics designed to enhance oral health for humans and pets under Evora and ProBiora brand names. Oragenics was founded by Jeffrey D. Hillman and Robert T. Zahradnik in November 1996 and is headquartered in Tampa, FL.

Contact Information

Oragenics, Inc.
4902 Eisenhower boulevard
Tampa Florida 33634
P:(813) 286-7900
Investor Relations:

Employees

Shareholders

Other institutional9.78%
Individual stakeholders47.72%
Mutual fund holders3.90%

Top Executives

John N. BonfiglioPresident, Chief Executive Officer & Director
Michael O'Keefe SullivanChief Financial Officer, Secretary & Treasurer
Martin HandfieldVice President-Research & Development
Albert G. FosmoeSenior VP-Operations & Product Development
Guojun NieDirector-Process Development

To view my watchlist

Not a member yet?

Sign up now for a free account
Market indexes are shown in real time, except for the DJIA, which is delayed by two minutes. All times are ET. Disclaimer Morningstar: © 2014 Morningstar, Inc. All Rights Reserved. Disclaimer The Dow Jones IndexesSM are proprietary to and distributed by Dow Jones & Company, Inc. and have been licensed for use. All content of the Dow Jones IndexesSM © 2014 is proprietary to Dow Jones & Company, Inc. Chicago Mercantile Association. The market data is the property of Chicago Mercantile Exchange Inc. and its licensors. All rights reserved. FactSet Research Systems Inc. 2014. All rights reserved. Most stock quote data provided by BATS.